Skip to content

Septerna, Inc.

SEPN· Nasdaqxbrl foundCIK 1984086

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -13.74%
Market cap
$1.99B
47.55M shares
Filings
179
$18.88M
Q3 2026+4,174.5% FY25 yoy
-$26.59M
Q3 2026N/M FY25 yoy
-$27.23M
Q3 2026N/M FY25 yoy
-$62.54M
Q3 2026derivedN/M FY25 yoy
-$0.57
Q3 2026N/M FY25 yoy
$167.12M
Q3 2026−49.3% FY25 yoy
$1.99B
—
20.7×
4.6×
-3.90%
—

Twelve months to Sep 30, 2026 · derived

Price

$41.84+117.44%+$22.60past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$45.95MFY 2025
$45.95M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$45,951,000reported
FY 20242024-12-31$1,075,000reported
FY 20232023-12-31$151,000reported

Pharmaceutical preparations

Septerna, Inc. is the 131st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Septerna, Inc. · CIK 1984086 · Engraved from SEC EDGAR